We are live on ! Find out more
ALIM

Alimera Sciences

Delisted

ALIM was delisted on the 13th of September, 2024.

64 hedge funds and large institutions have $141M invested in Alimera Sciences in 2015 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 26 increasing their positions, 16 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

11,300% more call options, than puts

Call options by funds: $1.03M | Put options by funds: $9K

63% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 16

0.9% more ownership

Funds ownership: 68.05%68.95% (+0.9%)

0% more funds holding

Funds holding: 6464 (0)

0% more funds holding in top 10

Funds holding in top 10: 55 (0)

0% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 8

6% less capital invested

Capital invested by funds: $151M → $141M (-$9.79M)

Holders
64
Holders Change
Holders Change %
0%
% of All Funds
1.72%
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.13%
New
8
Increased
26
Reduced
16
Closed
8
Calls
$1.03M
Puts
$9K
Net Calls
+$1.02M
Net Calls Change
+$1.13M

ALIM Hedge Fund Activity: Q2 2015 in Review

64 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q2 2015, worth a combined $141M — down 6.5% from $151M a quarter earlier.

Fund positioning in ALIM was balanced in Q2 2015: 8 funds opened new positions, 8 closed out, 26 added to existing stakes and 16 trimmed.

The largest buyer was North Run Capital, adding an estimated $2.18M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $1.16M sold.

  • 64 institutional investors held Alimera Sciences (ALIM) as of Q2 2015, unchanged from Q1 2015.
  • Funds reported $141M of Alimera Sciences stock for Q2 2015, down 6.5% quarter-over-quarter.
  • 8 funds opened new Alimera Sciences positions in Q2 2015 and 8 closed out, a net change of 0 holders.
  • The largest Alimera Sciences buyer in Q2 2015 was North Run Capital, an estimated $2.18M added.
  • The largest Alimera Sciences seller in Q2 2015 was Perceptive Advisors, an estimated $1.16M sold.

Based on aggregated 13F filings for Q2 2015.